Published in IARC Sci Publ on January 01, 1987
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J Biol Chem (2001) 2.79
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol (1999) 2.78
Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J Biol Chem (1998) 2.72
Substrate positions and induced-fit in crystalline adenylate kinase. J Mol Biol (1977) 2.69
Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers. Nat Struct Biol (1998) 2.35
Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress. Mol Microbiol (2000) 2.19
Influence of dietary nitrate on nitrite content of human saliva: possible relevance to in vivo formation of N-nitroso compounds. Food Cosmet Toxicol (1976) 1.88
Thioredoxin reductase two modes of catalysis have evolved. Eur J Biochem (2000) 1.70
The thioredoxin system of the malaria parasite Plasmodium falciparum. Glutathione reduction revisited. J Biol Chem (2000) 1.63
Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem (2000) 1.63
Glutathione reductase from human erythrocytes. The sequences of the NADPH domain and of the interface domain. Eur J Biochem (1982) 1.63
The structure of the flavoenzyme glutathione reductase. Nature (1978) 1.61
The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli. Proc Natl Acad Sci U S A (1997) 1.56
Synthetic inhibitors of adenylate kinases in the assays for ATPases and phosphokinases. Eur J Biochem (1975) 1.55
Topological comparison of adenyl kinase with other proteins. Nature (1974) 1.45
Lung carcinoma induction in BD rats after a single intratracheal instillation of an arsenic-containing pesticide mixture formerly used in vineyards. Int J Cancer (1979) 1.40
Three-dimensional structure of glutathione reductase at 2 A resolution. J Mol Biol (1981) 1.32
Enzymatic reduction studies of nitroheterocycles. Biochem Pharmacol (1999) 1.32
Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells. Br J Cancer (2001) 1.24
A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase. Biochem J (1998) 1.23
The thioredoxin system of Plasmodium falciparum and other parasites. Cell Mol Life Sci (2002) 1.22
Trypanothione reductase from Trypanosoma cruzi. Purification and characterization of the crystalline enzyme. Eur J Biochem (1987) 1.21
Structural relationships in the adenylate kinase family. Eur J Biochem (1986) 1.18
[The particularities of contractile proteins of the arteries]. Biochem Z (1965) 1.18
FAD-binding site of glutathione reductase. J Mol Biol (1982) 1.18
5-Hydroxymethylfurfural: assessment of mutagenicity, DNA-damaging potential and reactivity towards cellular glutathione. Food Chem Toxicol (2000) 1.17
Folding of the four domains and dimerization are impaired by the Gly446-->Glu exchange in human glutathione reductase. Implications for the design of antiparasitic drugs. Biochemistry (1993) 1.13
The enzymatic synthesis of thiophosphate analogs of nucleotides. Biochim Biophys Acta (1972) 1.11
Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts. Cell Biochem Biophys (1998) 1.10
Inhibition of Trypanosoma cruzi trypanothione reductase by acridines: kinetic studies and structure-activity relationships. J Med Chem (1999) 1.08
Fluorescent and spin label probes of the environments of the sulfhydryl groups of porcine muscle adenylate kinase. J Biol Chem (1975) 1.07
Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS Lett (1998) 1.07
[Trace analysis of N-nitroso compounds. 3. Quantitative thin-layer chromatography of nitrosamines]. J Chromatogr (1970) 1.06
Glutathione reductase of the malarial parasite Plasmodium falciparum: crystal structure and inhibitor development. J Mol Biol (2003) 1.05
Oxidative stress as a defense mechanism against parasitic infections. Free Radic Res Commun (1987) 1.04
Trypanothione-dependent synthesis of deoxyribonucleotides by Trypanosoma brucei ribonucleotide reductase. J Biol Chem (2001) 1.04
Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest. Oncogene (2001) 1.02
Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A/indirubin-5-sulphonate. Structure (2001) 1.00
Glutathione reductase and glutamate dehydrogenase of Plasmodium falciparum, the causative agent of tropical malaria. Eur J Biochem (1996) 0.99
Risk characterisation of chemicals in food and diet. Food Chem Toxicol (2003) 0.99
Cloning and sequencing of mammalian glutathione reductase cDNA. Eur J Biochem (1990) 0.98
Glutathione reductase from human erythrocytes: amino-acid sequence of the structurally known FAD-binding domain. Eur J Biochem (1981) 0.97
Redox processes in malaria and other parasitic diseases. Determination of intracellular glutathione. Histochemistry (1994) 0.97
Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds. Eur J Biochem (1989) 0.96
The structure of Trypanosoma cruzi trypanothione reductase in the oxidized and NADPH reduced state. Proteins (1994) 0.96
Trypanosoma brucei tryparedoxin, a thioredoxin-like protein in African trypanosomes. FEBS Lett (1998) 0.95
3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition. Cancer Res (1993) 0.95
Nitrofuran drugs as common subversive substrates of Trypanosoma cruzi lipoamide dehydrogenase and trypanothione reductase. Biochem Pharmacol (1999) 0.95
Deletion of the parasite-specific insertions and mutation of the catalytic triad in glutathione reductase from chloroquine-sensitive Plasmodium falciparum 3D7. Mol Biochem Parasitol (2000) 0.94
A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. J Med Chem (2001) 0.94
Glutathione reductase-deficient erythrocytes as host cells of malarial parasites. Biochem Pharmacol (1988) 0.94
Glutathione reductase inhibitors as potential antimalarial drugs. Effects of nitrosoureas on Plasmodium falciparum in vitro. Biochem Pharmacol (1988) 0.94
Nitrate and nitrite in saliva. Oncology (1980) 0.93
Glutathione reductase from human erythrocytes. Isolation of the enzyme and sequence analysis of the redox-active peptide. Eur J Biochem (1977) 0.92
The bacterial redox signaller pyocyanin as an antiplasmodial agent: comparisons with its thioanalog methylene blue. Redox Rep (2011) 0.91
Human thioredoxin reductase is efficiently inhibited by (2,2':6',2' '-terpyridine)platinum(II) complexes. Possible implications for a novel antitumor strategy. J Med Chem (2001) 0.90
Recombinant putative glutathione reductase of Plasmodium falciparum exhibits thioredoxin reductase activity. Mol Biochem Parasitol (1996) 0.90
Crystal structure of the Trypanosoma cruzi trypanothione reductase.mepacrine complex. Proteins (1996) 0.89
Cloning, sequencing and functional expression of dihydrolipoamide dehydrogenase from the human pathogen Trypanosoma cruzi. Eur J Biochem (1997) 0.89
DNA adducts and DNA damage by antineoplastic and carcinogenic N-nitrosocompounds. J Cancer Res Clin Oncol (1986) 0.89
Inhibition of human glutathione reductase by S-nitrosoglutathione. Eur J Biochem (1995) 0.89
Role of active site tyrosine residues in catalysis by human glutathione reductase. Biochemistry (1998) 0.89
Cyclic 3',5'-nucleotide phosphodiesterases: potential targets for anticancer therapy. Chem Res Toxicol (2000) 0.89
Glutamate dehydrogenase, the marker protein of Plasmodium falciparum--cloning, expression and characterization of the malarial enzyme. Eur J Biochem (1998) 0.88
Primary and tertiary structure of the principal human adenylate kinase. Eur J Biochem (1976) 0.88
Studies on the stability of trialkyl phosphates and di-(2'deoxythymidine) phosphotriesters in alkaline and neutral solution. A model study for hydrolysis of phosphotriesters in DNA and on the influence of a beta hydroxyethyl ester group. Chem Biol Interact (1986) 0.88
2,3-diphenyl-1,4-naphthoquinone: a potential chemotherapeutic agent against Trypanosoma cruzi. J Parasitol (2009) 0.88
(2,2':6',2"-Terpyridine)platinum(II) complexes are irreversible inhibitors of Trypanosoma cruzi trypanothione reductase but not of human glutathione reductase. J Med Chem (2000) 0.88
Charge is the major discriminating factor for glutathione reductase versus trypanothione reductase inhibitors. Bioorg Med Chem (1996) 0.88
Metabolic activation of benzo[c]phenanthrene by cytochrome P450 enzymes in human liver and lung. Chem Res Toxicol (2001) 0.87
Purification and characterization of lipoamide dehydrogenase from Trypanosoma cruzi. Eur J Biochem (1990) 0.87
Risk assessment of substances that are both genotoxic and carcinogenic report of an International Conference organized by EFSA and WHO with support of ILSI Europe. Food Chem Toxicol (2006) 0.86
Identification and functional characterization of thioredoxin from Trypanosoma brucei brucei. J Biol Chem (2000) 0.86
Effects of antioxidants on glutathione levels and clinical recovery from the malnutrition syndrome kwashiorkor--a pilot study. Redox Rep (2005) 0.85
Kinetic characterization of glutathione reductase from the malarial parasite Plasmodium falciparum. Comparison with the human enzyme. J Biol Chem (2000) 0.85
1,3-Bis(2-chloroethyl)-1-nitrosourea as thiol-carbamoylating agent in biological systems. Methods Enzymol (1995) 0.85
Ajoene is an inhibitor and subversive substrate of human glutathione reductase and Trypanosoma cruzi trypanothione reductase: crystallographic, kinetic, and spectroscopic studies. J Med Chem (1999) 0.85
The structural isomerisation of human-muscle adenylate kinase as studied by 1H-nuclear magnetic resonance. Eur J Biochem (1982) 0.85
[A new method for the colorimetric determination of nitrosamines after cleavage of the N-nitroso-group with hydrogen bromide in glacial acetic acid]. Arzneimittelforschung (1970) 0.85
Generating compatible translation initiation regions for heterologous gene expression in Escherichia coli by exhaustive periShine-Dalgarno mutagenesis. Human glutathione reductase cDNA as a model. Nucleic Acids Res (1992) 0.85
Dinitrosyl-dithiol-iron complexes, nitric oxide (NO) carriers in vivo, as potent inhibitors of human glutathione reductase and glutathione-S-transferase. Biochem Pharmacol (1997) 0.85
Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells. Br J Cancer (2001) 0.84
Mutagenic and cytotoxic effectiveness of zinc dimethyl and zinc diisononyldithiocarbamate in human lymphocyte cultures. Mutat Res (2001) 0.84
Automated determination of DNA using the fluorochrome Hoechst 33258. Anal Biochem (1985) 0.84
Inhibition of human glutathione reductase by 10-arylisoalloxazines: crystalline, kinetic, and electrochemical studies. J Med Chem (1996) 0.84
Volatile nitrosamines in food. Oncology (1980) 0.84
Mitochondrial adenylate kinase (AK2) from bovine heart. Homology with the cytosolic isoenzyme in the catalytic region. Eur J Biochem (1984) 0.84
The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase. FEBS Lett (1997) 0.84
Antineoplastic activity of esters and amides of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-aminoacids. J Cancer Res Clin Oncol (1984) 0.84
Denaturation and reactivation of dimeric human glutathione reductase--an assay for folding inhibitors. Eur J Biochem (1997) 0.84
The influence of N7 substituents on the stability of N7-alkylated guanosines. Chem Biol Interact (1985) 0.84
Comparative study on the influence of two 2-chloroethylnitrosoureas with different carbamoylating potential towards glutathione and glutathione-related enzymes in different organs of the rat. Free Radic Res Commun (1991) 0.83